Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma Meeting Abstract


Authors: Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; Hakimi, A. A.; Adachi, Y.; Minoshima, Y.; Matsui, J.; Funahashi, Y.; Perini, R. F.; Nomoto, K.; Motzer, R. J.; Chan, T. A. T.
Abstract Title: Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
Meeting Title: 2020 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 6 Suppl.
Meeting Dates: 2020 Feb 13-15
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-20
Language: English
ACCESSION: WOS:000529525900735
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.6_suppl.733
Notes: Meeting Abstract: 733 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Robert Motzer
    1243 Motzer
  3. Darren Richard Feldman
    340 Feldman
  4. Martin Henner Voss
    288 Voss
  5. Abraham Ari Hakimi
    323 Hakimi
  6. Maria Isabel Carlo
    161 Carlo
  7. Vladimir Makarov
    57 Makarov
  8. Chung-Han   Lee
    157 Lee
  9. Chirag Krishna
    20 Krishna
  10. Natalie Shapnik
    16 Shapnik
  11. Samuel John Murray
    11 Murray